Watch JAGX. Know when insiders buy.
One email the day a filing lands. Free.
JAGX
Jaguar Health, Inc.
2.29
−0.34 −12.93%
USD · close Oct 21
A free account adds a watchlist, alerts when insiders, Congress or short sellers move on your tickers, and a morning brief. Sign up
Work order
0
FLAG · shorts 0
Insiders, 90 days
0
no open-market filings in 90 days
Congress, 90 days
0 / 0
no disclosures naming it
Big money
0 / 15
none of the tracked funds disclose it
Calls on record
0
nobody we score has called it yet
MKT CAP $392.4MP/E —DIV YIELD —FCF YIELD —REV TTM $27.8M +135.5%NET INCOME −$36.8MNET DEBT $2.2M52W 2.29 – 1,102.50SEC XBRL · TTM TO Invalid Date
Financials
By quarter
| Period | Revenue | YoY | Gross margin | Operating income | Net income | YoY | EPS | Op. cash flow | Capex | Free cash flow | Filed |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Q2 2026 · Jun 30 | $1.2M | −58.9% | 15.8% | −$7.6M | −$12.8M | — | -15.70 | −$5.3M | — | — | Aug 19 |
| Q1 2026 · Mar 31 | $20.3M | +815.6% | 94.3% | $10.2M | $8.7M | — | -13.60 | $8.8M | — | — | May 20 |
| Q4 2025 · Dec 31derived | $3.2M | −7.8% | 32.0% | −$21.2M | −$23.2M | — | -0.36 | −$5.5M | — | — | Apr 7 |
| Q3 2025 · Sep 30 | $3.1M | −0.8% | 82.7% | −$7.2M | −$9.5M | — | -6.28 | −$4.7M | — | — | Nov 14 |
| Q2 2025 · Jun 30 | $3M | +9.5% | 82.3% | −$8M | −$10.4M | — | -358.94 | −$6.2M | — | — | Aug 19 |
| Q1 2025 · Mar 31 | $2.2M | −5.8% | 76.7% | −$9.4M | −$10.5M | — | -584.45 | −$7.3M | — | — | May 20 |
| Q4 2024 · Dec 31derived | $3.5M | +52.6% | 84.1% | −$8.2M | −$9.9M | −130.9% | 20.03 | −$7.8M | $0 | −$7.8M | Apr 7 |
| Q3 2024 · Sep 30 | $3.1M | +10.5% | 82.6% | −$7.3M | −$9.9M | — | -26.29 | −$6.3M | $0 | −$6.3M | Nov 14 |
| Q2 2024 · Jun 30 | $2.7M | — | 84.3% | −$7.2M | −$9.5M | — | -2.66 | −$8.2M | — | — | Aug 14 |
| Q1 2024 · Mar 31 | $2.4M | — | 81.7% | −$8.2M | −$9.2M | — | -87.12 | −$7M | — | — | May 15 |
| Q4 2023 · Dec 31derived | $2.3M | — | 70.1% | −$7.6M | $32.1M | — | -2545.68 | −$7.5M | — | — | Apr 15 |
| Q3 2023 · Sep 30 | $2.8M | — | 81.7% | −$8.8M | −$7.8M | — | -22.50 | −$6.8M | $0 | −$6.8M | Nov 13 |
By fiscal year
| Year | Revenue | Gross margin | Operating income | Net income | Net margin | EPS | Op. cash flow | Capex | Free cash flow | Buybacks | Dividends paid |
|---|---|---|---|---|---|---|---|---|---|---|---|
| FY2025 · to Dec 31 | $11.5M | 67.2% | −$45.9M | −$53.6M | -465.4% | -22.97 | −$23.7M | — | — | — | — |
| FY2024 · to Dec 31 | $11.7M | 83.3% | −$30.8M | −$38.5M | -329.3% | -130.69 | −$29.4M | $16K | −$29.4M | — | — |
| FY2023 · to Dec 31 | $9.8M | 79.1% | −$34.3M | −$42K | -0.4% | -2678.17 | −$33.2M | — | — | — | — |
| FY2022 · to Dec 31 | $12M | 83.1% | −$34.4M | −$48K | -0.4% | -36.18 | −$33.1M | $77K | −$33.2M | — | — |
| FY2021 · to Dec 31 | $4.3M | 46.2% | −$40.7M | −$53K | -1.2% | -88.22 | −$35M | $6K | −$35M | — | — |
| FY2020 · to Dec 31 | $9.4M | 65.1% | −$26.6M | −$33.8M | -360.2% | -3.00 | −$15.3M | $7K | −$15.3M | — | — |
Every number comes from Jaguar Health, Inc.'s own XBRL-tagged filings with the SEC, not a data vendor. Quarters marked derived are the fiscal year minus the three reported quarters, the same way every data provider computes Q4. Restated figures replace originals as later filings arrive.